EA202092779A1 - Замещенные дигидропиразолопиразинкарбоксамидные производные - Google Patents
Замещенные дигидропиразолопиразинкарбоксамидные производныеInfo
- Publication number
- EA202092779A1 EA202092779A1 EA202092779A EA202092779A EA202092779A1 EA 202092779 A1 EA202092779 A1 EA 202092779A1 EA 202092779 A EA202092779 A EA 202092779A EA 202092779 A EA202092779 A EA 202092779A EA 202092779 A1 EA202092779 A1 EA 202092779A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- substituted
- dihydropyrazolopyrazine
- carboxamide derivatives
- preparation
- well
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Abstract
Настоящее изобретение относится к замещенным дигидропиразолопиразинкарбоксамидным производным и к способу их получения, а также к их применению для получения лекарственных средств для лечения и/или профилактики заболеваний, в частности сердечно-сосудистых нарушений, предпочтительно тромботических или тромбоэмболических нарушений и диабета, а также урогенитальных и офтальмологических нарушений.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2018087249 | 2018-05-17 | ||
PCT/EP2019/062005 WO2019219517A1 (en) | 2018-05-17 | 2019-05-10 | Substituted dihydropyrazolo pyrazine carboxamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202092779A1 true EA202092779A1 (ru) | 2021-02-02 |
Family
ID=66625151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202092779A EA202092779A1 (ru) | 2018-05-17 | 2019-05-10 | Замещенные дигидропиразолопиразинкарбоксамидные производные |
Country Status (25)
Country | Link |
---|---|
US (1) | US20220324865A1 (ru) |
EP (1) | EP3793559A1 (ru) |
JP (1) | JP2021523910A (ru) |
KR (1) | KR20210013084A (ru) |
CN (1) | CN112469412A (ru) |
AR (1) | AR114906A1 (ru) |
AU (1) | AU2019270142A1 (ru) |
BR (1) | BR112020021612A2 (ru) |
CA (1) | CA3100221A1 (ru) |
CL (1) | CL2020002974A1 (ru) |
CO (1) | CO2020014201A2 (ru) |
CR (1) | CR20200554A (ru) |
CU (1) | CU20200084A7 (ru) |
EA (1) | EA202092779A1 (ru) |
EC (1) | ECSP20072258A (ru) |
JO (1) | JOP20200294A1 (ru) |
MA (1) | MA52623A (ru) |
MX (1) | MX2020012201A (ru) |
NI (1) | NI202000083A (ru) |
PE (1) | PE20210856A1 (ru) |
PH (1) | PH12020551973A1 (ru) |
SG (1) | SG11202010679SA (ru) |
TW (1) | TW202012408A (ru) |
UY (1) | UY38237A (ru) |
WO (1) | WO2019219517A1 (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201811799A (zh) | 2016-09-09 | 2018-04-01 | 美商英塞特公司 | 吡唑并嘧啶化合物及其用途 |
IL292977A (en) | 2016-09-09 | 2022-07-01 | Incyte Corp | Pyrazolopyridine derivatives as modulators of hpk1 and their use in cancer therapy |
WO2018049214A1 (en) | 2016-09-09 | 2018-03-15 | Incyte Corporation | Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer |
MD3755703T2 (ro) | 2018-02-20 | 2022-10-31 | Incyte Corp | Derivați N-(fenil)-2-(fenil)pirimidin-4-carboxamidă și compuși înrudiți ca inhibitori HPK1 pentru tratarea cancerului |
US10752635B2 (en) | 2018-02-20 | 2020-08-25 | Incyte Corporation | Indazole compounds and uses thereof |
US10899755B2 (en) | 2018-08-08 | 2021-01-26 | Incyte Corporation | Benzothiazole compounds and uses thereof |
CA3147918A1 (en) | 2019-08-06 | 2021-02-11 | Incyte Corporation | Solid forms of an hpk1 inhibitor |
WO2021094209A1 (en) | 2019-11-12 | 2021-05-20 | Bayer Aktiengesellschaft | Substituted pyrrolo triazine carboxamide derivatives as prostaglandin ep3 receptor antagonists |
WO2021094210A1 (en) * | 2019-11-12 | 2021-05-20 | Bayer Aktiengesellschaft | Substituted pyrazine carboxamide derivatives as prostaglandin ep3 receptor antagonists |
WO2021094208A1 (en) * | 2019-11-12 | 2021-05-20 | Bayer Aktiengesellschaft | Substituted imidazo pyrimidine ep3 antagonists |
CN114236017B (zh) * | 2022-02-23 | 2022-06-07 | 深圳市海滨制药有限公司 | 一种棕榈酸抗坏血酸酯及其杂质的检测方法 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
DE19834047A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
DE19943639A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften |
DE19943635A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943636A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943634A1 (de) | 1999-09-13 | 2001-04-12 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
AR031176A1 (es) | 2000-11-22 | 2003-09-10 | Bayer Ag | Nuevos derivados de pirazolpiridina sustituidos con piridina |
DE10110750A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE10110749A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte Aminodicarbonsäurederivate |
DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
CN101146540A (zh) * | 2004-06-09 | 2008-03-19 | 默克公司 | Hiv整合酶抑制剂 |
DE102004054665A1 (de) | 2004-11-12 | 2006-05-18 | Bayer Cropscience Gmbh | Substituierte bi- und tricyclische Pyrazol-Derivate Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren |
DE102007032349A1 (de) * | 2007-07-11 | 2009-01-15 | Bayer Healthcare Ag | Imidazo-, Pyrazolopyrazine und Imidazotriazine und ihre Verwendung |
EP2187883A2 (en) | 2007-08-10 | 2010-05-26 | Genelabs Technologies, Inc. | Nitrogen containing bicyclic chemical entities for treating viral infections |
WO2009082687A1 (en) | 2007-12-21 | 2009-07-02 | Genentech, Inc. | Azaindolizines and methods of use |
DE102010001064A1 (de) | 2009-03-18 | 2010-09-23 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung |
LT2539326T (lt) | 2010-02-27 | 2017-08-10 | Bayer Intellectual Property Gmbh | Sujungti bisariliniai ariltriazolonai ir jų panaudojimas |
DE102010021637A1 (de) | 2010-05-26 | 2011-12-01 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung |
WO2012004258A1 (de) | 2010-07-09 | 2012-01-12 | Bayer Pharma Aktiengesellschaft | Annellierte pyrimidine und triazine und ihre verwendung zur behandlung bzw. prophylaxe von herz-kreislauf-erkrankungen |
DE102010040233A1 (de) | 2010-09-03 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Bicyclische Aza-Heterocyclen und ihre Verwendung |
DE102010043379A1 (de) | 2010-11-04 | 2012-05-10 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung |
EP2675440B1 (en) | 2011-02-14 | 2020-03-25 | Merck Sharp & Dohme Corp. | Cathepsin cysteine protease inhibitors |
ES2585044T3 (es) * | 2012-03-28 | 2016-10-03 | Merck Patent Gmbh | Derivados de pirazinona bicíclicos |
KR20150130491A (ko) | 2013-03-13 | 2015-11-23 | 제넨테크, 인크. | 피라졸로 화합물 및 그것의 용도 |
CA2926568C (en) * | 2013-10-09 | 2017-09-05 | Pfizer Inc. | Antagonists of prostaglandin ep3 receptor |
ES2659045T3 (es) * | 2013-10-30 | 2018-03-13 | Bayer Pharma Aktiengesellschaft | Derivados de oxopiridina sustituidos |
WO2015129821A1 (ja) | 2014-02-27 | 2015-09-03 | 国立大学法人東京大学 | オートタキシン阻害活性を有する縮合ピラゾール誘導体 |
RS58049B1 (sr) | 2014-11-03 | 2019-02-28 | Bayer Pharma AG | Hidroksialkilom supstituisani derivati feniltriazola i njihova upotreba |
WO2016103097A1 (en) | 2014-12-22 | 2016-06-30 | Pfizer Inc. | Antagonists of prostaglandin ep3 receptor |
EP3712153B1 (en) | 2016-02-24 | 2021-12-01 | Pfizer Inc. | Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors |
-
2019
- 2019-05-10 EA EA202092779A patent/EA202092779A1/ru unknown
- 2019-05-10 KR KR1020207035904A patent/KR20210013084A/ko unknown
- 2019-05-10 CU CU2020000084A patent/CU20200084A7/es unknown
- 2019-05-10 EP EP19725298.4A patent/EP3793559A1/en not_active Withdrawn
- 2019-05-10 MX MX2020012201A patent/MX2020012201A/es unknown
- 2019-05-10 WO PCT/EP2019/062005 patent/WO2019219517A1/en active Application Filing
- 2019-05-10 PE PE2020001842A patent/PE20210856A1/es unknown
- 2019-05-10 US US17/055,190 patent/US20220324865A1/en not_active Abandoned
- 2019-05-10 CA CA3100221A patent/CA3100221A1/en active Pending
- 2019-05-10 JO JOP/2020/0294A patent/JOP20200294A1/ar unknown
- 2019-05-10 AU AU2019270142A patent/AU2019270142A1/en not_active Abandoned
- 2019-05-10 JP JP2020564100A patent/JP2021523910A/ja active Pending
- 2019-05-10 MA MA052623A patent/MA52623A/fr unknown
- 2019-05-10 CN CN201980046621.4A patent/CN112469412A/zh active Pending
- 2019-05-10 CR CR20200554A patent/CR20200554A/es unknown
- 2019-05-10 BR BR112020021612-7A patent/BR112020021612A2/pt not_active Application Discontinuation
- 2019-05-10 SG SG11202010679SA patent/SG11202010679SA/en unknown
- 2019-05-15 TW TW108116681A patent/TW202012408A/zh unknown
- 2019-05-17 UY UY0001038237A patent/UY38237A/es unknown
- 2019-05-17 AR ARP190101323A patent/AR114906A1/es unknown
-
2020
- 2020-11-11 EC ECSENADI202072258A patent/ECSP20072258A/es unknown
- 2020-11-16 CL CL2020002974A patent/CL2020002974A1/es unknown
- 2020-11-17 CO CONC2020/0014201A patent/CO2020014201A2/es unknown
- 2020-11-17 NI NI202000083A patent/NI202000083A/es unknown
- 2020-11-18 PH PH12020551973A patent/PH12020551973A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW202012408A (zh) | 2020-04-01 |
UY38237A (es) | 2019-11-29 |
ECSP20072258A (es) | 2020-12-31 |
CO2020014201A2 (es) | 2021-03-08 |
MA52623A (fr) | 2021-03-24 |
EP3793559A1 (en) | 2021-03-24 |
CR20200554A (es) | 2021-01-12 |
PH12020551973A1 (en) | 2021-08-02 |
NI202000083A (es) | 2021-03-11 |
CU20200084A7 (es) | 2021-06-08 |
PE20210856A1 (es) | 2021-05-18 |
CL2020002974A1 (es) | 2021-03-05 |
CA3100221A1 (en) | 2019-11-21 |
AR114906A1 (es) | 2020-10-28 |
SG11202010679SA (en) | 2020-11-27 |
US20220324865A1 (en) | 2022-10-13 |
MX2020012201A (es) | 2021-01-29 |
BR112020021612A2 (pt) | 2021-01-26 |
AU2019270142A1 (en) | 2020-11-12 |
JOP20200294A1 (ar) | 2020-11-17 |
JP2021523910A (ja) | 2021-09-09 |
KR20210013084A (ko) | 2021-02-03 |
WO2019219517A1 (en) | 2019-11-21 |
CN112469412A (zh) | 2021-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA202092779A1 (ru) | Замещенные дигидропиразолопиразинкарбоксамидные производные | |
EA201890111A1 (ru) | Замещенные производные оксопиридина | |
EA202191764A1 (ru) | Замещенные оксопиридиновые производные | |
TN2015000434A1 (en) | Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders | |
EA201792354A1 (ru) | Композиции обетихолевой кислоты и способы применения | |
CY1125025T1 (el) | 2-φορμυλ-3-υδροξυφαινυλοξυμεθυλ ενωσεις ικανες ρυθμισης αιμοσφαιρινης | |
EA201790377A1 (ru) | Антитела к глюкагону и их применения | |
EA201891374A1 (ru) | Замещенные 2-фенил-3-(пиперазинметил)имидазопиридины и их применение | |
EA202091709A1 (ru) | Ингибиторы днк-пк | |
EA201690212A8 (ru) | Способы лечения или профилактики офтальмологических патологических состояний | |
EA201591535A1 (ru) | Замещенные производные 3-фенилпропиламина для лечения офтальмологических заболеваний и расстройств | |
EA202091020A1 (ru) | Замещенные имидазопиридинамиды и их применение | |
WO2016046156A8 (de) | Substituierte oxopyridin-derivate | |
EA201500112A1 (ru) | 3-замещенные производные эстра-1,3,5(10),16-тетраена, способы их получения, фармацевтические средства, которые их содержат, и их использование для получения лекарственных средств | |
EA201600288A1 (ru) | Замещенные фенилаланиновые производные | |
EA202091708A1 (ru) | Ингибиторы днк-пк | |
EA201890002A1 (ru) | Положительные аллостерические модуляторы мускаринового рецептора м2 | |
EA201791945A1 (ru) | Пирролидинкарбоксамидопроизводные и способы их получения и их применение | |
CA3082254A1 (en) | Heterocyclic compounds as kinase inhibitors | |
MA39171A1 (fr) | Dérivés d'hydroxy formamide et leur utilisation | |
EA201792341A1 (ru) | Производные пиразола, пригодные в качестве ингибиторов белка, активирующего 5-липоксигеназу (flap) | |
CY1124492T1 (el) | 7-υποκατεστημενα 1-αρυλο-ναφθυριδιν-3-καρβοξαμιδια και η χρηση αυτων | |
EA202193038A1 (ru) | Антитела против sema3a и их применения для лечения заболеваний глаз | |
EA202190094A1 (ru) | Антитела против cd40 для применения в лечении аутоиммунного заболевания | |
EA202191115A1 (ru) | Новые пиридазины |